Private Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $836K | Hold |
6,000
| – | – | 0.06% | 106 |
|
|
2025
Q4 | $736K | Hold |
6,000
| – | – | 0.05% | 115 |
|
|
2025
Q3 | $666K | Hold |
6,000
| – | – | 0.05% | 112 |
|
|
2025
Q2 | $665K | Hold |
6,000
| – | – | 0.05% | 114 |
|
|
2025
Q1 | $672K | Sell |
6,000
-3,050
| -34% | -$315K | 0.06% | 109 |
|
|
2024
Q4 | $836K | Buy |
9,050
+50
| +0.6% | +$4.5K | 0.06% | 99 |
|
|
2024
Q3 | $755K | Sell |
9,000
-15,094
| -63% | -$1.15M | 0.06% | 101 |
|
|
2024
Q2 | $1.65M | Sell |
24,094
-47,147
| -66% | -$3.15M | 0.12% | 72 |
|
|
2024
Q1 | $5.22M | Buy |
71,241
+26,350
| +59% | +$2.03M | 0.42% | 36 |
|
|
2023
Q4 | $3.64M | Buy |
44,891
+5,827
| +15% | +$453K | 0.31% | 44 |
|
|
2023
Q3 | $2.93M | Buy |
39,064
+1,815
| +5% | +$140K | 0.28% | 45 |
|
|
2023
Q2 | $2.87M | Buy |
37,249
+16,785
| +82% | +$1.34M | 0.26% | 46 |
|
|
2023
Q1 | $1.7M | Buy |
20,464
+540
| +3% | +$44.7K | 0.17% | 58 |
|
|
2022
Q4 | $1.71M | Buy |
19,924
+84
| +0.4% | +$6.65K | 0.2% | 57 |
|
|
2022
Q3 | $1.22M | Sell |
19,840
-1,000
| -5% | -$63.1K | 0.16% | 58 |
|
|
2022
Q2 | $1.29M | Sell |
20,840
-56,570
| -73% | -$3.5M | 0.15% | 62 |
|
|
2022
Q1 | $4.6M | Sell |
77,410
-195
| -0.3% | -$12.5K | 0.41% | 44 |
|
|
2021
Q4 | $5.63M | Buy |
77,605
+44,195
| +132% | +$3.04M | 0.48% | 41 |
|
|
2021
Q3 | $2.33M | Buy |
33,410
+3,555
| +12% | +$250K | 0.22% | 54 |
|
|
2021
Q2 | $2.06M | Buy |
29,855
+6,595
| +28% | +$440K | 0.19% | 60 |
|
|
2021
Q1 | $1.5M | Buy |
23,260
+7,300
| +46% | +$471K | 0.16% | 62 |
|
|
2020
Q4 | $930K | Sell |
15,960
-136,575
| -90% | -$8.24M | 0.1% | 71 |
|
|
2020
Q3 | $9.64M | Buy |
152,535
+9,100
| +6% | +$631K | 1.13% | 25 |
|
|
2020
Q2 | $11M | Buy |
143,435
+128,835
| +882% | +$9.87M | 1.51% | 20 |
|
|
2020
Q1 | $1.09M | Buy |
+14,600
| New | +$1.01M | 0.18% | 64 |
|
|
2016
Q3 | – | Sell |
-53,935
| Closed | -$4.5M | – | 123 |
|
|
2016
Q2 | $4.5M | Sell |
53,935
-7,440
| -12% | -$660K | 1.08% | 33 |
|
|
2016
Q1 | $5.64M | Buy |
61,375
+12,350
| +25% | +$1.11M | 1.36% | 25 |
|
|
2015
Q4 | $4.96M | Buy |
49,025
+29,760
| +154% | +$3.1M | 1.16% | 31 |
|
|
2015
Q3 | $1.89M | Buy |
19,265
+5,675
| +42% | +$630K | 0.48% | 52 |
|
|
2015
Q2 | $1.59M | Buy |
13,590
+2,150
| +19% | +$235K | 0.36% | 63 |
|
|
2015
Q1 | $1.12M | Buy |
11,440
+3,110
| +37% | +$316K | 0.26% | 78 |
|
|
2014
Q4 | $785K | Sell |
8,330
-34,510
| -81% | -$3.57M | 0.18% | 88 |
|
|
2014
Q3 | $4.56M | Buy |
42,840
+4,635
| +12% | +$454K | 1% | 26 |
|
|
2014
Q2 | $3.17M | Buy |
+38,205
| New | +$2.97M | 0.7% | 41 |
|
Other funds holding GILD
VCM
VPM
Private Wealth Partners's GILD Position: Q1 2026 in Review
Private Wealth Partners held its Gilead Sciences (GILD) position steady in Q1 2026 at 6,000 shares worth $836K. The position accounts for 0.06% of the portfolio, ranked #106.
Private Wealth Partners first reported a position in GILD in Q2 2014 and has held it in 34 quarters since. The position peaked at $11M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Private Wealth Partners held 6,000 shares of Gilead Sciences worth $836K as of Q1 2026.
- Private Wealth Partners left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.06% of Private Wealth Partners's portfolio in Q1 2026, its #106 holding.
- Private Wealth Partners first reported a position in Gilead Sciences in Q2 2014 and has held it in 34 quarters since.
- Private Wealth Partners's Gilead Sciences position peaked at $11M in Q2 2020.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Private Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.